Form 8-K - Current report:
SEC Accession No. 0001279569-24-000186
Filing Date
2024-02-22
Accepted
2024-02-22 11:54:57
Documents
17
Period of Report
2024-02-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K fourfront8k.htm   iXBRL 8-K 29087
2 NEWS RELEASE DATED FEBRUARY 20, 2024 ex991.htm EX-99.1 7235
3 GRAPHIC logo.jpg GRAPHIC 8404
4 GRAPHIC image_001.jpg GRAPHIC 10721
  Complete submission text file 0001279569-24-000186.txt   236363

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20240220.xsd EX-101.SCH 3094
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20240220_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20240220_pre.xml EX-101.PRE 22372
19 EXTRACTED XBRL INSTANCE DOCUMENT fourfront8k_htm.xml XML 3407
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 24663323
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)